Making Patent Prosecution More Collaborative
An article authored by Andrew Mathis titled “Making Patent Prosecution More Collaborative” was published in the Massachusetts Bar Association’s November/December 2024 issue of Section Review. In this ...
Biotechnology (2)
Boston Intellectual Property Law Association Comments to USPTO on Notice of Proposed Rulemaking Regarding Terminal Disclaimer Practice
Jonathan Roses authored on behalf of the Boston Intellectual Property Law Association (BIPLA) a July 2024 Comment to USPTO on Notice of Proposed Rulemaking Regarding Terminal Disclaimer Practice. The ...
Proposed March-In Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-Dole Act
An article authored by Rob Sahr and Curtis Powell titled “Proposed March-In Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-Dole Act” was published in Volume 16...
A Look Ahead: Key Intellectual Property Legal Topics in 2024
What should in-house counsel be on the lookout for in 2024? As we begin a new year, our attorneys look ahead at intellectual property topics they expect will be trending in 2024. They cover areas incl...
Best Practices for Orange Book Listings
An article authored by Jonathan Roses titled “Best Practices for Orange Book Listings” was published in The Pharma Letter as an “Expert View.” In this article, Jon provides insights into how to succes...
An Emerging PTAB Threat for Bio/Pharma: Leveraging Written Description Vulnerabilities in IPR
Bio/pharma patents are rarely targeted in inter partes review (IPR) proceedings because their technical vulnerabilities often relate to written description and/or enablement. IPR, of course, is restri...
Trends in Life Sciences Innovation: Six Things You Need to Know
What is top of mind right now for in-house life sciences IP counsel? I recently attended the Life Sciences Patent Network (LSPN) North America conference in Boston, and was lucky enough to moderate a ...
How to Avoid Potential Loss of IP and Confidential Information for Start-ups
(originally published by FORGE) The innovative idea behind your product is what makes it exciting and valuable to consumers and investors. As a start-up leader, your business success depends on keepin...
Federal Circuit Affirms As Obvious Suite of Patents Directed to Methods Of Treating Opioid Overdose
Introduction In February of 2022, the Federal Circuit affirmed a New Jersey District Court’s determination that four patents claiming methods of treating opioid overdose by intranasal administration o...
Issue Preclusion Means One Strike and You Are Out
While issue preclusion means one strike and you are out, a court might need to call a few balls before calling the strike that ends the case.
Kite Flies Away With CAR-T Patent Challenge Win Based on Written Description Battle
In Juno Therapeutics v. Kite Pharma, the Court of Appeals for the Federal Circuit (CAFC) reversed a $1.2 billion dollar judgment to Juno, finding that Juno’s asserted claims, which they alleged were i...
Extending Ezra: Federal District Court Declines to “Cut Off” Patent Term Adjustment in View of Alleged Obviousness-Type Double Patenting in Mitsubishi v. Sandoz
In Mitsubishi Tanabe Pharma Corp. v. Sandoz, Inc., the District Court for the District of New Jersey considered whether a patent receiving patent term adjustment (PTA) may be invalidated for obviousne...